BRAF mutation correlates with worse local–regional control following radiation therapy in patients w...
BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
In patients with stage III melanoma, the use of adjuvant radiation therapy (RT) after lymph node dissection (LND) may be currently considered in selected high-risk patients to improve tumor control. Melanomas harbor BRAF mutations (BRAF+) in 40-50% of cases, the majority of which are on the V600E residue. This study sought to compare the clinical o...
Alternative Titles
Full title
BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4aed581dd5ab4a64bc414077d7b5400f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4aed581dd5ab4a64bc414077d7b5400f
Other Identifiers
ISSN
1748-717X
E-ISSN
1748-717X
DOI
10.1186/s13014-021-01903-5
